Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Int J Mol Sci ; 25(3)2024 Jan 30.
Article in English | MEDLINE | ID: mdl-38338982

ABSTRACT

We had previously investigated the expression and functional role of C-X-C Motif Chemokine Ligand 12 (CXCL12) during the hair cycle progression. CXCL12 was highly expressed in stromal cells such as dermal fibroblasts (DFs) and inhibition of CXCL12 increased hair growth. Therefore, we further investigated whether a CXCL12 neutralizing antibody (αCXCL12) is effective for androgenic alopecia (AGA) and alopecia areata (AA) and studied the underlying molecular mechanism for treating these diseases. In the AGA model, CXCL12 is highly expressed in DFs. Subcutaneous (s.c.) injection of αCXCL12 significantly induced hair growth in AGA mice, and treatment with αCXCL12 attenuated the androgen-induced hair damage in hair organ culture. Androgens increased the secretion of CXCL12 from DFs through the androgen receptor (AR). Secreted CXCL12 from DFs increased the expression of the AR and C-X-C Motif Chemokine Receptor 4 (CXCR4) in dermal papilla cells (DPCs), which induced hair loss in AGA. Likewise, CXCL12 expression is increased in AA mice, while s.c. injection of αCXCL12 significantly inhibited hair loss in AA mice and reduced the number of CD8+, MHC-I+, and MHC-II+ cells in the skin. In addition, injection of αCXCL12 also prevented the onset of AA and reduced the number of CD8+ cells. Interferon-γ (IFNγ) treatment increased the secretion of CXCL12 from DFs through the signal transducer and activator of transcription 3 (STAT3) pathway, and αCXCL12 treatment protected the hair follicle from IFNγ in hair organ culture. Collectively, these results indicate that CXCL12 is involved in the progression of AGA and AA and antibody therapy for CXCL12 is promising for hair loss treatment.


Subject(s)
Alopecia Areata , Antibodies, Neutralizing , Animals , Mice , Alopecia/metabolism , Alopecia Areata/drug therapy , Alopecia Areata/metabolism , Androgens/metabolism , Antibodies, Neutralizing/pharmacology , Antibodies, Neutralizing/metabolism , Hair , Hair Follicle/metabolism , Skin/metabolism , Chemokine CXCL12/immunology
2.
Korean J Gastroenterol ; 77(6): 300-304, 2021 06 25.
Article in English | MEDLINE | ID: mdl-34158450

ABSTRACT

Eosinophilic colitis is a rare disease that is characterized by eosinophilic infiltration in the colon wall in symptomatic patients. Thus far, the epidemiology and pathophysiology of eosinophilic colitis have not been well defined, but the hypersensitivity response is likely to play a role in its pathogenesis. The clinical presentation of eosinophilic colitis is usually nonspecific and depends on the layer of the intestinal wall affected by the eosinophilic infiltrate. Eosinophilic colitis is diagnosed generally by exclusion, i.e., after all other causes of eosinophilic infiltration have been excluded. Although there is no consensus over its diagnostic criteria, the laboratory results and radiology and endoscopy findings can provide important diagnostic evidence. This paper reports a case of eosinophilic colitis presenting as subepithelial tumor-like lesions in a 41-year-old man with the chief complaints of abdominal pain and loose stools. The patient had no diseases and no food or drug allergies in his medical history. In general, the endoscopic findings of eosinophilic colitis can vary from a normal mucosa to frank ulcerations. In this case, however, endoscopy revealed subepithelial tumor-like lesions. The colon biopsy showed eosinophilic infiltration in the lamina propria. The patient was treated with steroids, and his symptoms regressed with no signs of relapse.


Subject(s)
Colitis , Eosinophilia , Neoplasms , Adult , Colitis/diagnosis , Diarrhea , Eosinophilia/diagnosis , Humans , Male
3.
J Clin Med ; 9(7)2020 Jul 06.
Article in English | MEDLINE | ID: mdl-32640699

ABSTRACT

Parkinson's disease (PD) is the most common neurodegenerative movement disorder, characterized by olfactory dysfunction in the early stages. α-Synuclein pathologies in the olfactory organs are shown to spread to the brain through the nose-brain axis. We first developed a nasal epithelial PD cellular model by treating RPMI-2650 cells with α-synuclein preformed fibrils (PFF). Upon uptake of PFF, RPMI-2650 cells showed mitochondrial proteome alteration and downregulation of parkin, which has previously been identified as a nasal biomarker of PD. Functional cluster analysis of differentially expressed genes in RPMI-2650 cells revealed various pathways affected by α-synuclein pathology, including the detection of chemical stimulus involved in sensory perception, olfactory receptor activity, and sensory perception of smell. Among genes that were most affected, we validated, by real-time quantitative PCR, the downregulation of MAP3K8, OR10A4, GRM2, OR51B6, and OR9A2, as well as upregulation of IFIT1B, EPN1, OR1D5, LCN, and OTOL1 in PFF-treated RPMI-2650 cells. Subsequent analyses of clinical samples showed a downregulation of OR10A4 and OR9A2 transcripts and an upregulation of IFIT1B in cells isolated from the nasal fluid of PD patients, as compared to those from the controls (cutoff value = 0.5689 for OR9A2, with 72.4% sensitivity and 75% specificity, and 1.4658 for IFIT1B, with 81.8% sensitivity and 77.8% specificity). Expression levels of these nasal PD markers were not altered in nasal fluid cells from SWEDD (scans without evidence of dopaminergic deficits) patients with PD-like motor symptoms. These nasal markers were significantly altered in patients of PD with hyposmia compared to the control hyposmic subjects. Our results validated the α-synuclein-treated nasal epithelial cell model to identify novel biomarkers for PD and suggest the utility of olfactory transcripts, along with olfactory dysfunction, in the diagnosis of PD.

4.
Nanomaterials (Basel) ; 10(1)2019 Dec 18.
Article in English | MEDLINE | ID: mdl-31861378

ABSTRACT

The addition of small amounts of carbon nanotubes (CNTs) to cement-based materials modifies their thermal and electrical characteristics. This study investigated the void detection and filling rates of cement grout with multi-walled carbon nanotubes (MWCNTs). MWCNT grouts of 40 mm × 40 mm × 160 mm were fabricated. Specimens were tested by thermal imaging, electrical resistance analyses, and magnetic field tests. The experimental parameters were the concentration of MWCNT and the grout filling rate. The filling rate was investigated by measuring resistance and magnetic field changes with respect to cross-sectional area, taking the voids into consideration. The results of the thermal image tests indicate that 1.0 wt% MWCNT cement grout is optimal for void detection.

5.
J Nanobiotechnology ; 17(1): 19, 2019 Jan 29.
Article in English | MEDLINE | ID: mdl-30696428

ABSTRACT

BACKGROUND: Protein-based Cas9 in vivo gene editing therapeutics have practical limitations owing to their instability and low efficacy. To overcome these obstacles and improve stability, we designed a nanocarrier primarily consisting of lecithin that can efficiently target liver disease and encapsulate complexes of Cas9 with a single-stranded guide RNA (sgRNA) ribonucleoprotein (Cas9-RNP) through polymer fusion self-assembly. RESULTS: In this study, we optimized an sgRNA sequence specifically for dipeptidyl peptidase-4 gene (DPP-4) to modulate the function of glucagon-like peptide 1. We then injected our nanocarrier Cas9-RNP complexes directly into type 2 diabetes mellitus (T2DM) db/db mice, which disrupted the expression of DPP-4 gene in T2DM mice with remarkable efficacy. The decline in DPP-4 enzyme activity was also accompanied by normalized blood glucose levels, insulin response, and reduced liver and kidney damage. These outcomes were found to be similar to those of sitagliptin, the current chemical DPP-4 inhibition therapy drug which requires recurrent doses. CONCLUSIONS: Our results demonstrate that a nano-liposomal carrier system with therapeutic Cas9-RNP has great potential as a platform to improve genomic editing therapies for human liver diseases.


Subject(s)
CRISPR-Cas Systems , Diabetes Mellitus, Type 2/therapy , Dipeptidyl Peptidase 4/genetics , Drug Delivery Systems , Genetic Therapy/methods , Lecithins , Liposomes , Animals , Blood Glucose/drug effects , Cell Line , Dipeptidyl Peptidase 4/metabolism , Gene Editing , Gene Targeting , Glucagon-Like Peptide 1/blood , Humans , Lecithins/administration & dosage , Lecithins/chemistry , Liposomes/administration & dosage , Liposomes/chemistry , Mice , Mice, Knockout , RNA, Guide, Kinetoplastida/administration & dosage , RNA, Guide, Kinetoplastida/chemistry , RNA, Guide, Kinetoplastida/genetics
6.
Int J Mol Sci ; 19(4)2018 Apr 11.
Article in English | MEDLINE | ID: mdl-29641498

ABSTRACT

Cutaneous wound repair is an intricate process whereby the skin reprograms itself after injury. In the mid-phase of wound repair, the proliferation, migration, and differentiation of cells are the major mechanisms to lead remodeling. We investigated the effect of BMM ((1E,2E)-1,2-bis((6-bromo-2H-chromen-3-yl)methylene)hydrazine), a novel synthetic material, on the migration and viability of keratinocytes or fibroblasts using the in vitro scratch woundhealing, electric cell-substrate imedance sensing (ECIS), invasion, and MTT assays. Cell migration-related factors were analyzed using western blot, and we found that treatment with BMM stimulated the EMT pathway and focal adhesion kinase (FAK)/Src signaling. Differentiation of HaCaT keratinocyte and fibroblast cells was also stimulated by BMM and specifically, NOX2/4 contributed to the activation of fibroblasts for wound healing. Furthermore, BMM treated HaCaT keratinocyte and fibroblast-co-cultured cells increased migration and differentiation. TGF-ß and Cyr61 were also secreted to a greater extent than in single cultured cells. In vivo experiments showed that treatment with BMM promotes wound closure by promoting re-epithelialization. In this study, we demonstrated that a novel synthetic material, BMM, is capable of promoting wound healing via the stimulation of re-epithelialization in the epidermis and the activation of fibroblasts in the dermis, in particular, via the acceleration of the interaction between the epidermis and dermis.


Subject(s)
Benzopyrans/pharmacology , Fibroblasts/drug effects , Hydrazines/pharmacology , Re-Epithelialization , Animals , Benzopyrans/chemistry , Cell Line , Cell Movement , Cell Proliferation , Cells, Cultured , Cysteine-Rich Protein 61/metabolism , Fibroblasts/metabolism , Fibroblasts/physiology , Focal Adhesion Protein-Tyrosine Kinases/metabolism , Humans , Hydrazines/chemistry , Keratinocytes/drug effects , Keratinocytes/metabolism , Keratinocytes/physiology , Male , Mice , Mice, Inbred ICR , NADPH Oxidases/metabolism , Signal Transduction , Transforming Growth Factor beta/metabolism , src-Family Kinases/metabolism
7.
J Photochem Photobiol B ; 102(2): 102-7, 2011 Feb 07.
Article in English | MEDLINE | ID: mdl-21185197

ABSTRACT

The 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging effect and total phenolic contents were evaluated for the screening of singlet oxygen ((1)O(2)) quenching efficacy of various seed extracts from Rumex crispus L. The butanol and ethyl-acetate extracts displayed remarkable effect of DPPH as compared to positive control ascorbic acid. The concentrations (QC(50)) of butanol and ethyl-acetate extracts required to exert 50% reducing effect on (1)O(2) were found to be 116 and 82 µg mL(-1), respectively. Both extracts were also found to protect the in vitro biological system from the detrimental effect of (1)O(2) on type II photosensitization in Escherichia coli, red blood cell, lactate dehydrogenase and histidine. Among all the tested extracts, the ethyl-acetate and butanol extracts contained higher amount of total phenolic contents. The results suggest that our study may contribute to the development of new bioactive products with potential applications to reduce photo-produced oxidative stress involving reactive oxygen species in living organisms.


Subject(s)
Free Radical Scavengers/chemistry , Plant Extracts/chemistry , Rumex/chemistry , Singlet Oxygen/metabolism , Biphenyl Compounds/chemistry , Biphenyl Compounds/pharmacology , Erythrocytes/drug effects , Escherichia coli/drug effects , Free Radical Scavengers/pharmacology , Gas Chromatography-Mass Spectrometry , Histidine/metabolism , Humans , Kinetics , L-Lactate Dehydrogenase/metabolism , Phenols/chemistry , Phenols/pharmacology , Photosensitizing Agents/chemistry , Photosensitizing Agents/metabolism , Picrates/chemistry , Picrates/pharmacology , Plant Extracts/pharmacology , Seeds/chemistry , Singlet Oxygen/chemistry
8.
J Biosci Bioeng ; 111(3): 279-85, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21095157

ABSTRACT

The aim of this study was to optimize the culture conditions for the production of biological cyclic hexadepsipeptides (enniatins H, I and MK1688) from Fusarium oxysporum KFCC 11363P. Tests of 10 complete or chemically defined liquid culture media revealed that Fusarium defined medium was the best for the production of enniatins (produced amounts: enniatin H, 185.4 mg/L; enniatin I, 349.1mg/L; enniatin MK1688, 541.1mg/L; and total enniatins, 1075.6 mg/L). On the eighth day after inoculation, the maximal production of enniatins was observed at 25°C in Fusarium defined medium. The optimal carbon and nitrogen sources for producing biological cyclic hexadepsipeptides (enniatins H, I, and MK1688) were sucrose and NaNO(3), respectively, and their optimal concentrations were determined by the principle of response surface methodology. It was confirmed that using the optimized growth medium compositions increased the amounts of enniatins H, I, and MK1688, and total enniatins produced to 695.2, 882.4, 824.8, and 2398.5mg/L, respectively. These findings will assist in formulating microbiological media useful for enniatin research.


Subject(s)
Culture Media/chemistry , Depsipeptides/biosynthesis , Fermentation , Fusarium/metabolism , Carbon/metabolism , Fusarium/growth & development , Models, Statistical , Nitrates/metabolism , Nitrogen/metabolism , Sucrose/metabolism
9.
Opt Express ; 16(4): 2520-7, 2008 Feb 18.
Article in English | MEDLINE | ID: mdl-18542332

ABSTRACT

9.953 GHz phase-modulated continuous-wave laser combs are spectrally broadened via nonlinear propagation in normal and anomalous dispersion media and experimentally characterized using a differential phase shift keying (DPSK) decoder. DPSK bit-error rate data are in qualitative agreement with radio-frequency spectrum analyzer measurements.

10.
Plant Physiol ; 143(1): 389-99, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17114277

ABSTRACT

Hydrogen peroxide produced from the nectar redox cycle was shown to be a major factor contributing to inhibition of most microbial growth in floral nectar; however, this obstacle can be overcome by the floral pathogen Erwinia amylovora. To identify the source of superoxide that leads to hydrogen peroxide accumulation in nectary tissues, nectaries were stained with nitroblue tetrazolium. Superoxide production was localized near nectary pores and inhibited by diphenylene iodonium but not by cyanide or azide, suggesting that NAD(P)H oxidase is the source of superoxide. Native PAGE assays demonstrated that NADPH (not NADH) was capable of driving the production of superoxide, diphenyleneiodonium chloride was an efficient inhibitor of this activity, but cyanide and azide did not inhibit. These results confirm that the production of superoxide was due to an NADPH oxidase. The nectary enzyme complex was distinct by migration on gels from the leaf enzyme complex. Temporal expression patterns demonstrated that the superoxide production (NADPH oxidase activity) was coordinated with nectar secretion, the expression of Nectarin I (a superoxide dismutase in nectar), and the expression of NOX1, a putative gene for a nectary NADPH oxidase that was cloned from nectaries and identified as an rbohD-like NADPH oxidase. Further, in situ hybridization studies indicated that the NADPH oxidase was expressed in the early stages of flower development although superoxide was generated at later stages (after Stage 10), implicating posttranslational regulation of the NADPH oxidase in the nectary.


Subject(s)
NADPH Oxidases/physiology , Nicotiana/enzymology , Plant Proteins/physiology , Azides/pharmacology , Cloning, Molecular , Cyanides/pharmacology , Electrophoresis, Gel, Two-Dimensional , Escherichia coli/drug effects , Flowers/drug effects , Flowers/enzymology , Flowers/physiology , Hydrogen Peroxide/metabolism , Microbial Sensitivity Tests , Molecular Sequence Data , NADPH Oxidases/antagonists & inhibitors , NADPH Oxidases/genetics , Onium Compounds/pharmacology , Phylogeny , Plant Preparations/pharmacology , Plant Proteins/antagonists & inhibitors , Plant Proteins/genetics , Superoxides/antagonists & inhibitors , Superoxides/metabolism , Nicotiana/cytology , Nicotiana/drug effects
11.
J Cataract Refract Surg ; 31(3): 614-9, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15811753

ABSTRACT

PURPOSE: To determine the role of nuclear factor kappa B (NF-kappaB) in the death of lens epithelial cells (LECs) after ultraviolet (UV) irradiation. SETTING: Department of Ophthalmology, Ilsan Paik Hospital, Inje University, Korea. METHODS: Cultures of simian virus 40 transfected human LECs (HLE B-3 cells) were were irradiated with a UVB source (312 nm) located 10 cm from the bottom of the slides for 1, 2, 3, or 4 minutes. Cytotoxicity was evaluated using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide method. Translocation of NF-kappaB was examined by immunocytochemistry using anti-NF-kappaB p65 antibody and electrophoretic mobility shift assay (EMSA). Sulfasalazine, a specific NF-kappaB inhibitor, was used to confirm the role of NF-kappaB by pretreating samples for 30 minutes before UV irradiation, after which cytotoxicity and NF-kappaB translocation were evaluated. RESULTS: When HLE B-3 cells were irradiated with UVB, translocation of NF-kappaB was observed with immunocytochemistry. These translocations peaked during EMSA 6 hours after UV irradiation. In HLE B-3 cells pretreated with sulfasalazine, the translocation of NF-kappaB was blocked. Cellular death after UV irradiation was also markedly reduced by sulfasalazine pretreatment. Ultraviolet irradiation can translocate NF-kappaB, and sulfasalazine is a useful blocking agent in this pathway. In this experimental model, sulfasalazine prevented cellular death after UV irradiation. CONCLUSION: The findings suggest that NF-kappaB plays an important role in cellular death after UV irradiation.


Subject(s)
Apoptosis , Epithelial Cells/radiation effects , Lens, Crystalline/cytology , NF-kappa B/metabolism , Ultraviolet Rays , Cell Survival , Cells, Cultured , Electrophoretic Mobility Shift Assay , Epithelial Cells/metabolism , Epithelial Cells/pathology , Fluorescent Antibody Technique, Indirect , Humans , Microscopy, Fluorescence , NF-kappa B/antagonists & inhibitors , Sulfasalazine/pharmacology
12.
Front Biosci ; 9: 1611-25, 2004 May 01.
Article in English | MEDLINE | ID: mdl-14977572

ABSTRACT

Pyrimidine nucleotides represent one of the most fundamental of cellular components. They are the building blocks for the direct synthesis of DNA and RNA that function in information storage and retrieval within the cell, but they also participate in the metabolism of a large number of other cellular components from sugar interconversion to cellular polysaccharides to glycoproteins and phospholipids. Thus, the metabolism of pyrimidine nucleotides and their intracellular pool sizes influence vast areas of normal cellular metabolism. The first pyrimidine, UMP, is synthesized by a de novo pathway that appears to be mechanistically invariant in all organisms. UMP is then further modified to form other pyrimidines. Breakdown of deoxyribo- and ribonucleic acids, the main sink for pyrimidine nucleotides, allows pyrimidines to be reutilized for resynthesis of these important cellular components. Pyrimidines are salvaged by converting the modified components into the free base, uracil for reutilization. Finally, pyrimidines are degraded into simple cellular metabolites permitting reutilization of nitrogen and carbon from pyrimidine ring systems into cellular metabolic pools. The regulation of pyrimidine metabolism is tightly controlled in plants. Additionally, plants produce toxic secondary metabolites derived from pyrimidines for use as defense compounds.


Subject(s)
Plants/metabolism , Pyrimidine Nucleotides/metabolism , Pyrimidines/metabolism , Models, Chemical , Plants/enzymology , Pyrimidine Nucleotides/biosynthesis , Pyrimidine Nucleotides/chemistry , Pyrimidines/biosynthesis , Pyrimidines/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...